Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TADAWUL/2070 stock hub

TADAWUL/2070 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TADAWUL/2070is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.5B

Saudi Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TADAWUL/2070

In the news

Latest news · TADAWUL/2070

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.3

P25 15.3P50 18.4P75 19.8

Trailing P/E19.8

P25 16.2P50 19.4P75 30.1

ROE11

P25 9.3P50 15.6P75 21.4

ROIC7.3

P25 7P50 12P75 21

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TADAWUL/2070 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

SAR

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Saudi Arabia
Country code	SA
Enterprise value	SAR 4.6B
Exchange	Saudi Stock Exchange
Financial currency	SAR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	SA0007879188
Last refreshed	2026-05-10
Market cap	SAR 3.5B
Price	SAR 29.74
Price currency	SAR
Sector	Healthcare
Sic	2834
Symbol	tadawul/2070
Website	https://www.spimaco.com.sa

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.03%
EV Earnings	26.03x
EV/EBIT	18.35x
EV/EBITDA	13.75x
EV/FCF	16.43x
EV/Sales	2.83x
FCF yield	7.97%
Forward P/E	18.31x
P/B ratio	1.94x
P/E ratio	19.8x
P/S ratio	2.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.95%
EBITDA Margin	18.62%
FCF margin	17.2%
Gross margin	50.3%
Gross Profit	SAR 827.9M
Gross Profit Growth	4.29%
Gross Profit Growth Q	3.15%
Gross Profit Growth3 Y	9.59%
Gross Profit Growth5 Y	5.66%
Net Income	SAR 178.6M
Net Income Growth	197.62%
Net Income Growth Q	-8.12%
Net Income Growth Years	3%
Net Income Growth5 Y	11.14%
Pretax Margin	12.94%
Profit Margin	10.85%
Profitable Years	2
ROA	3.28
Roa5y	0.96
ROCE	9.37
ROE	11.02
Roe5y	0.8
ROIC	7.35
Roic5y	-2.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.29%
Cagr15y	3.39%
Cagr1y	14.4%
Cagr20y	0.64%
Cagr3y	5.82%
Cagr5y	-6.38%
Div CAGR10	-7.5%
Div CAGR3	-26.32%
Div CAGR5	-9.71%
EPS Growth	199.3
EPS Growth Q	-7.25
EPS Growth Years	3
EPS Growth5 Y	11.34
FCF Growth Q	11,668.66%
OCF Growth Q	504.03%
Revenue Growth	-2.67x
Revenue Growth Q	-12.58x
Revenue Growth Years	3x
Revenue Growth3 Y	1.71x
Revenue Growth5 Y	1.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SAR 0.38
Assets	SAR 4.3B
Cash	SAR 341.6M
Current Assets	SAR 2.3B
Current Liabilities	SAR 1.8B
Debt	SAR 1.3B
Debt EBITDA	SAR 4.05
Debt Equity	SAR 0.7
Debt FCF	SAR 4.5
Equity	SAR 1.8B
Interest Coverage	2.73
Liabilities	SAR 2.4B
Long Term Assets	SAR 2B
Long Term Liabilities	SAR 621M
Net Cash	SAR -931.7M
Net Cash By Market Cap	SAR -26.25
Net Debt EBITDA	SAR 3.04
Net Debt Equity	SAR 0.51
Net Debt FCF	SAR 3.29
Tangible Book Value	SAR 1.6B
Tangible Book Value Per Share	SAR 13.18
WACC	6.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.26
Inventory Turnover	1.36
Net Working Capital	SAR 1.1B
Quick ratio	0.86
Working Capital	SAR 470.9M
Working Capital Turnover	SAR 2.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.57%
Dividend per share	SAR 0.35
Dividend Yield	1.18%
Last Dividend	SAR 0.6

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-2.85%
1Y total return	14.39%
200-day SMA	28.41
3Y total return	18.49%
50-day SMA	29.82
50-day SMA vs 200-day SMA	50over200
5Y total return	-28.09%
All Time High	206.5
All Time High Change	-85.6%
All Time High Date	2006-02-16
All Time Low	9.42
All Time Low Change	215.88%
All Time Low Date	1999-03-08
ATR	0.97
Beta	0.46
Beta1y	-0.13
Beta2y	0.3
Ch YTD	14.12
High	30.4
High52	33.12
High52 Date	2026-04-22
High52ch	-10.21%
Low	29
Low52	21.76
Low52 Date	2025-06-15
Low52ch	36.67%
Ma50ch	-0.25%
Price vs 200-day SMA	4.69%
RSI	43.42
RSI Monthly	50.11
RSI Weekly	95.16
Sharpe ratio	0.53x
Sortino ratio	0.97
Total Return	1.75%
Tr YTD	14.12
Tr15y	64.86%
Tr1m	-5.29%
Tr1w	-5.29%
Tr3m	-1.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SAR 229.6M
Operating Income Growth	81.45
Operating Income Growth Q	36.53
Operating Income Growth5 Y	14.7
Operating margin	13.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	86,493,196%
Net Borrowing	-289,812,000
Shares Insiders	0.16%
Shares Institutions	4.31%
Shares Out	119,355,000
Shares Qo Q	-0.87%
Shares Yo Y	-0.57%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SAR 282M
Average Volume	813,007.5x
Bv Per Share	14.04
CAPEX	SAR -82.3M
Ch10y	-18.07
Ch15y	17.23
Ch1m	-5.29
Ch1w	-5.29
Ch1y	14.39
Ch20y	-41.5
Ch3m	-1.26
Ch3y	18.49
Ch5y	-30.84
Ch6m	-3.69
Change	-2.36%
Change From Open	-2.17
Close	30.46
Days Gap	-0.2
Depreciation Amortization	76,886,000
Dollar Volume	24,362,145.5
Earnings Date	2026-04-13
EBIT	SAR 229.6M
EBITDA	SAR 306.4M
EPS	SAR 1.5
F Score	6
FCF	SAR 283M
FCF EV Yield	6.09x
FCF Per Share	SAR 2.37
Financing CF	-288,853,000
Fiscal Year End	December
Founded	1,986
Graham Number	21.77915
Graham Upside	-26.77
Income Tax	SAR 23.1M
Investing CF	-95,928,000
Is Primary Listing	1
Last Earnings Date	2025-11-10
Last Report Date	2026-03-31
Last Split Date	2014-04-20
Last Split Type	Forward
Lynch Fair Value	SAR 16.73
Lynch Upside	-43.74
Ma150	28.93
Ma150ch	2.8%
Ma20	31.17
Ma20ch	-4.58%
Net CF	-16,748,000
Open	30.4
P FCF Ratio	12.54
P OCF Ratio	9.72
Position In Range	52.86
Ppne	1,767,535,000
Price Date	2026-05-07
Price EBITDA	SAR 11.58
Ptbv Ratio	2.28
Relative Volume	1.01x
Revenue	1,645,702,000x
SBC By Revenue	0.06x
Share Based Comp	941,000
Tax By Revenue	1.4x
Tax Rate	10.84%
Tr20y	13.7%
Tr6m	-3.69%
Volume	819,171

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TADAWUL/2070 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.35 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-9.7%

Annualized growth of the per-share dividend

Total shareholder yield

+1.7%

Dividend yield + buyback yield combined

Performance

TADAWUL/2070 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TADAWUL/2070?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.3%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.6%

Negative means the company is buying back shares.

Technical

TADAWUL/2070 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.4

Neutral momentum band

Price vs 200-day MA

+4.7%

50/200-day relationship not available

Beta (5Y)

0.46

Less volatile than the market

Sharpe ratio

0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TADAWUL/2070

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tadawul/2070 stock rating?

tadawul/2070 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tadawul/2070 analysis?

The full report lives at /stocks/tadawul/2070/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tadawul/2070?

The latest report frames tadawul/2070 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tadawul/2070 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.